Journals / Tıp Fakültesi Klinikleri Dergisi / 2021 / Cilt: 4 - Sayı: 2

PATHOGENESIS OF OLFACTORY DYSFUNCTIONS IN THE COVID-19 PANDEMIC; UP TO DATE REVİEW

COVİD-19 PANDEMİSİ VE KOKU BOZUKLUĞU PATOGENESİ; GÜNCEL BİR DERLEME

Pages
49–55
Publication Date
2021-07-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Studies revealing the pathophysiology are important for understanding the postviral olfactory loss as well as developing new treatment modalities

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Covid 19 pandemic caused by corona virüs come along with olfactory loss, unlike its previous outbreaks.
📊
Key Findings & Data:It has been observed that the olfactory loss has an isolated, sudden onset type and usually clinical course was a total loss.
💡
Conclusion & Impact:Studies revealing the pathophysiology are important for understanding the postviral olfactory loss as well as developing new treatment modalities
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Covid-19 pandemisi · koku kaybı · patogenez

Abstract

Covid 19 pandemic caused by corona virüs come along with olfactory loss, unlike its previous outbreaks. It has been observed that the olfactory loss has an isolated, sudden onset type and usually clinical course was a total loss. It was seen in most of the patients without nasal obstruction or rhinorrhea, and olfactory dysfunction may occur before, with or after the general symptoms. Hypotheses for the development of olfactory loss include the loss of olfactory sensorial neurons, damage to the supporting cells in the olfactory epithelium, the neurotropic potential of coronaviruses, and their affecting the olfactory bulbus and or olfactory-related brain areas. Studies revealing the pathophysiology are important for understanding the postviral olfactory loss as well as developing new treatment modalities

Özet

Bir solunum yolu enfeksiyon ajanı olarak bilinen korona virüs kaynaklı covid 19 pandemisi, daha önceki salgınlarından farklı olarak koku kaybı ile ön plana çıkmıştır. Koku kaybının izole, ani başlangıçlı ve genellikle total kayıp şeklinde klinik seyre sahip olduğu, hastaların önemli kısmında nasal obstrüksiyon veya rinore olmadan görüldüğü ve olfaktor disfonksiyonun genel semptomlardan önce, bu semptomlarla birlikte veya sonradan ortaya çıkabildiği görülmiştür. Koku kaybı gelişimi ile ilgili hipotezler arasında olfaktor sensoryal nöronların kaybı, olfaktor epiteldeki destek hücrelerinin hasar görmesi, koronavirüslerin nörotropik potansiyeli ile olfaktor bulbus ve veya kokuyla ilişkili beyin alanlarını etkilemesi yer almaktadır. Patofizyolojiyi ortaya koyan bu çalışmalar postviral koku kaybına ışık tutacağı gibi yeni tedavi modaliteleri geliştirmek açısından da önem arz etmektedir.

🔖

Cite This Article

SAATCİ, Ö., BATIOĞŞU-KARAALTIN, A. (2021). PATHOGENESIS OF OLFACTORY DYSFUNCTIONS IN THE COVID-19 PANDEMIC; UP TO DATE REVİEW. Tıp Fakültesi Klinikleri Dergisi, Cilt: 4 - Sayı: 2, 49–55. https://ajindex.com/articles/844576

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Huart C, Philpott C, Konstantinidis I, et al. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology. 2020; 58: 623-25
  2. Temmel AFP, Quint C, Schickinger-Fischer B, et al. Characteristics of Olfactory Disorders in Relation to Major Causes of Olfactory Loss. Archives of Otolaryngology–Head & Neck Surgery. 2002; 128: 635-41
  3. Bohmwald K, Gálvez NMS, Ríos M, et al. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018; 12: 386-86
  4. Suzuki M, Saito K, Min WP, et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007; 117: 272-7
  5. Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan. 2006; 15: 26-8
  6. Zegarra-Valdivia JA, Chino-Vilca BN, Tairo-Cerron T, et al. Neurological Components in Coronavirus Induced Disease: A Review of the Literature Related to SARS, MERS, and COVID-19. Neurology Research International. 2020; 2020: 6587875
  7. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
  8. Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020 Jun 1;58(3):299-301
  9. Altundag A, Saatci O, Sanli DET, et al. The temporal course of COVID-19 anosmia and relation to other clinical symptoms. Eur Arch Otorhinolaryngol. 2020: 1-7. 10. von Bartheld CS, Hagen MM, Butowt R. Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences. ACS Chem Neurosci. 2020; 11: 2944-61
  10. Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020; 323: 2512-14
  11. Lechien JR, Chiesa-Estomba CM, Hans S, et al. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Ann Intern Med. 2020; 173: 672-75
  12. Vaira LA, Salzano G, Deiana G, et al. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020; 130: 1787
  13. Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist. 2020: 1073858420956905-05
  14. Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B be